Higher expression of oncogene PCNAP1 and downregulation of tumor suppressor LPAL2 are correlated with poor prognosis in HCC patients, underscoring the potential of pseudogene-derived lncRNAs to serve as prognostic indicators and therapeutic targets in HCC 8, 9. The gene discussed is LPAL2; the disease is hepatocellular carcinoma.